IP Library Granted Patent US 7,846,724
Granted Patent B2
US 7,846,724 · App. 11/732,974 · Granted Dec 7, 2010

Method for selecting CHO cell for production of glycosylated antibodies

Assignee: Hoffmann-La Roche Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,724
App. No.
11/732,974
Granted
Dec 7, 2010
Kind
B2
Abstract

The invention provides an antibody comprising human IgG1 or IgG3 heavy chain constant domains that are glycosylated with a sugar chain at Asn297, said antibody being characterized in that the amount of fucose within said sugar chain is at least 99%, and in addition the amount of NGNA is 1% or less and/or the amount of N-terminal alpha 1,3 galactose is 1% or less, and uses thereof.

Claims (9)

1. A method for the selection of a CHO cell that recombinantly produces a monoclonal antibody comprising human IgG1 or IgG3 heavy chain constant domains, wherein the heavy chain constant domains are glycosylated with a sugar chain at Asn297, wherein the sugar chain comprises at least 99% fucose, wherein if the sugar chain comprises N-glycolylneuraminic acid then the amount of N-glycolylneuraminic acid is 1% or less of the sugar chain and wherein if the sugar chain comprises N-terminal alpha-1,3-galactose then the amount of N-terminal alpha-1,3-galactose is 1% or less of the sugar chain;

the method comprising:

(1) cultivating a CHO cell transfected with an expression vector that encodes the heavy and light chains of a monoclonal antibody comprising human IgG1 or IgG3 heavy chain constant domains, wherein two DHFR alleles are deleted from the genome of the CHO cell;

(2) applying DHFR selection pressure;

(3) picking single clones;

(4) expanding the clones;

(5) producing antibodies from the clones;

(6) analyzing glycosylation of the antibodies produced from the clones; and

(7) selecting a clone that produces an antibody wherein the heavy chain constant domains are glycosylated with a sugar chain at Asn297, wherein the sugar chain comprises at least 99% fucose, wherein if the sugar chain comprises N-glycolylneuraminic acid then the amount of N-glycolylneuraminic acid is 1% or less of the sugar chain and wherein if the sugar chain comprises N-terminal alpha-1,3-galactose then the amount of N-terminal alpha-1,3-galactose is 1% or less of the sugar chain.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2007
From: F. HOFFMAN-LA ROCHE AG
To: HOFFMAN-LA ROCHE INC
Reel/Frame 019876/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2007
From: HANSEN, SILKE; KUENKELE, KLAUS-PETER; REUSCH, DIETMAR; SCHUMACHER, RALF
To: F. HOFFMAN-LA ROCHE AG
Reel/Frame 019877/0135 →
Priority Claims (2)
EP 06007565 · Apr 11, 2006 · regional
EP 06016203 · Aug 3, 2006 · regional
Continuity (1)
Related Publication 20070248600A1 · Oct 25, 2007